L-Histidine Encyclopedia — Scientific Background

What Is L-Histidine?

L-Histidine (CAS 71-00-1), also known as (2S)-2-amino-3-(1H-imidazol-4-yl)propanoic acid or α-amino-1H-imidazole-4-propionic acid, is an essential proteinogenic amino acid with the molecular formula C₆H₉N₃O₂ and a molecular weight of 155.16 g/mol. It occurs as white crystals or a crystalline powder that is odorless and has a slightly bitter taste. L-Histidine is a basic amino acid characterized by an imidazole side chain, which confers unique chemical properties including metal chelation, antioxidant activity, and pH buffering capacity.

The Essentiality of L-Histidine

The essentiality of histidine has been historically debated. The initial nonessentiality of histidine was determined based on amino acid depletion studies during a low-protein diet, but the short duration of these studies (6–8 days) did not lead to negative nitrogen balance, and histidine was initially classified as a nonessential amino acid. These studies were challenged approximately two decades later by Kopple and Swendseid, who provided evidence that histidine is an essential amino acid.

Indicators of histidine deficiency—including negative nitrogen balance, reduced serum albumin and hematocrit, and skeletal muscle catabolism—arose when a small number of individuals were fed a histidine-deficient diet for an extended period of time (mean 35 ± 2 days). With ingestion of the histidine-deficient diet, nitrogen balance gradually became negative, and serum albumin decreased in six subjects. Plasma histidine fell by 82 ± 6%, muscle histidine decreased by 62 ± 19%, the hematocrit fell by 25 ± 9%, and serum iron rose. Subjects felt unwell, and in five cases, a skin lesion consisting of fine scales, dry skin, and mild erythema developed. After administration of the histidine-repletion diet, nitrogen balance became positive, serum albumin increased, and the clinical symptoms and skin lesions disappeared. These observations indicate that histidine is an essential amino acid in normal and chronically uremic man.

Physiological Functions of L-Histidine

L-Histidine is an essential amino acid with several critical physiological roles:

• Carnosine Precursor — L-Histidine is the direct precursor to carnosine (β-alanyl-L-histidine), a potent endogenous antioxidant and anti-glycation dipeptide synthesized in skeletal muscle and brain tissue. Most functional properties of carnosine come from the imidazole ring in its structure, and both carnosine and L-histidine have almost identical antioxidant functions.

• Immune Function — Histidine is the precursor for histamine, which is important for the immune system by mediating growth and functionality of immune cells. In vitro studies show that 2 mM histidine addition to culture medium prevented apoptosis, enhanced cell growth, and elevated antibody production in lymphocytes.

• Metabolic Health — Supplementation with 4.0–4.5 g histidine/d and increased dietary histidine intake are associated with decreased BMI, adiposity, markers of glucose homeostasis, proinflammatory cytokines, and oxidative stress.

• Cognitive Function — Histidine intake also improves cognitive function (reduces appetite, anxiety, and stress responses and improves sleep) potentially through the metabolism of histidine to histamine.

• Skin Health — Histidine can be deaminated by histidine-ammonia lyase to produce urocanic acid (UCA), a unique photoreceptor. Histidine-induced skin trans-UCA levels suggest a role of histidine in immune function, particularly in the skin.

Mechanisms of Action

Carnosine Synthesis and Antioxidant Defense

L-Histidine is one of the two amino acid precursors for carnosine synthesis, along with β-alanine. Carnosine is synthesized in mammalian skeletal muscle via carnosine synthase and is found not only in skeletal muscle but also in the brain and other tissues. The dipeptide functions as a potent antioxidant, anti-glycation agent, and reactive carbonyl species detoxifier. It has been stated that β-alanine regulates histidine metabolic fate and activates the synergistic effect with histidine in reactive carbonyl species detoxification.

Histamine Synthesis and Immune Modulation

Histidine is converted to histamine by the enzyme histidine decarboxylase (HDC). Histamine adjusts many physiological and immunological processes through activation of different histamine receptors on target cells. Histamine is synthesized in mast cells and basophils by the action of HDC on L-histidine and is the major chemical mediator implicated in allergic reactions, vasodilation, and immune responses. Histamine also activates platelet congregation and induces Th2 cell activity by both decreasing IL-12 and increasing IL-10 production.

Metabolic Regulation and Glucose Homeostasis

Small clinical trials in prediabetes and obesity (4–8 g/day) demonstrated that histidine supplementation improved postprandial glucose, increased mucosal-associated invariant T (MAIT) cells, and shifted the gut microbiota and epigenetic regulation of the amino acid transporter SLC7A5. Supplementation with 4.0–4.5 g histidine/d is associated with decreased BMI, adiposity, markers of glucose homeostasis (HOMA-IR, fasting blood glucose, 2-h postprandial blood glucose), proinflammatory cytokines, and oxidative stress. It is unclear whether the improvements in glucoregulatory markers are due to reduced BMI and adiposity, increased carnosine (a metabolic product of histidine with antioxidant effects), or both.

Urocanic Acid and Skin Immune Function

In addition to histamine synthesis, histidine can be deaminated by the action of histidine-ammonia lyase to produce urocanic acid (UCA). UCA is a unique photoreceptor, and its transformation from cis-UCA to trans-UCA initiates the immune reductive action of solar ultraviolet-B. Studies suggest the role of histidine in immune function, particularly in the skin.

Clinical Evidence

Metabolic Health — Clinical Trials in Prediabetes and Obesity

Small clinical trials in prediabetes and obesity (4–8 g/day) improved postprandial glucose, increased mucosal-associated invariant T (MAIT) cells, and shifted the gut microbiota and epigenetic regulation of the amino acid transporter SLC7A5. Supplementation with doses of 4.0–4.5 g histidine/d and increased dietary histidine intake are associated with decreased BMI, adiposity, markers of glucose homeostasis (HOMA-IR, fasting blood glucose, 2-h postprandial blood glucose), proinflammatory cytokines, and oxidative stress.

Safety and Tolerability — Clinical Data

Histidine loading (with a dose of 0.054 g/kg) has been safely applied in pediatric leukemia to assess folate status. Most inherited deficiencies in key histidine-catabolic enzymes are largely phenotypically silent, and individuals with histidine ammonia lyase deficiency, resulting in fourfold to tenfold higher circulating histidine, exhibit no major illness. At high intakes of histidine (>24 g/d), studies report adverse effects such as decreased serum zinc and cognitive impairment. In humans, at a dose of 4 g histidine/d for 2 weeks, serum or urinary zinc concentrations were not altered.

Cancer Immunotherapy — Translational Research

Given the prevalence of folate depletion in patients with cancer, controlled dietary histidine supplementation merits further investigation, stratifying on gut dysbiosis, as an adjunct to immunotherapy in patients with first-line stage III or IV cancer, particularly in older patients or as an interpretive measure to prevent or delay cancer incidence in individuals at high cancer risk.

The Bioavailability Challenge

Despite its essential physiological functions, native L-histidine presents significant absorption challenges. The compound is absorbed from the small intestine via an active transport mechanism requiring the presence of sodium, which can be saturated at high doses. Additionally, L-histidine competes with other amino acids for transport across the intestinal epithelium, limiting the fraction that reaches systemic circulation.

liposomal encapsulation addresses these limitations through a phospholipid bilayer that protects L-histidine during digestive transit and provides an alternative absorption pathway that bypasses the competitive amino acid transporter.

Liposomal L-Histidine

Liposomal encapsulation of L-histidine provides a fundamentally different delivery mechanism from conventional forms. The phospholipid bilayer surrounds the L-histidine molecule, forming a protective shell that enhances stability, absorption, and cellular uptake. This delivery system:

• Achieves >97% encapsulation efficiency with <30% cumulative release over 5 days

• Bypasses saturable intestinal transporters through lipid-mediated absorption

• Provides sustained release for prolonged carnosine synthesis and antioxidant activity

• Enhances water dispersibility for use in aqueous formulations

Liposomal amino acid delivery systems have been extensively studied for their ability to enhance the stability and bioavailability of essential amino acids. The encapsulation efficiency of amino acids in liposomes exceeds 97%, with cumulative release rates below 30% for 5 days, demonstrating excellent retention and controlled release characteristics.

Safety and Regulatory

L-Histidine is generally well tolerated at commonly used doses. The current estimated requirement for histidine for healthy adults is 8–12 mg per kg body weight per day. Human research has used between 1 gram and 8 grams per day. At high intakes of histidine (>24 g/d), studies report adverse effects such as decreased serum zinc and cognitive impairment. There is limited research on the effects of histidine intake at doses between 4.5 and 24 g/d, and thus, a tolerable upper level has not been established.

Regulatory status varies by region:

• United States — L-Histidine is regulated as a dietary supplement ingredient. The FDA Substances Added to Food database lists L-Histidine with CAS Registry No. 71-00-1, with technical effects as a flavor enhancer, flavoring agent or adjuvant, and nutrient supplement. L-Histidine is Generally Recognized As Safe (GRAS) under 21 CFR § 582.5361 when used in accordance with good manufacturing or feeding practice. It is also regulated under 21 CFR § 172.320 for use as a food additive, with a limit not exceeding 2.4 percent by weight of total protein (expressed as free amino acid).

• European Union — L-Histidine is authorized for use in food and food supplements in EU member states.

• Global Standards — L-Histidine is monographed in the USP, European Pharmacopoeia, and Japanese Pharmacopoeia, with an assay specification of 98.5%–101.5% on dried basis.

Testing protocols must adhere to international standards including USP, European Pharmacopoeia, and FAO/WHO Codex Alimentarius. Formulators should verify local regulatory requirements prior to market entry.

This product is intended for research, nutraceutical, and functional food applications. Not intended to diagnose, treat, cure, or prevent any disease.

99$/KG